Squarepoint Ops LLC Buys 4,591 Shares of Iradimed Corporation (NASDAQ:IRMD)

Squarepoint Ops LLC grew its holdings in shares of Iradimed Corporation (NASDAQ:IRMD - Free Report) by 41.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 15,764 shares of the medical equipment provider's stock after purchasing an additional 4,591 shares during the period. Squarepoint Ops LLC owned 0.12% of Iradimed worth $867,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of IRMD. State of Wyoming bought a new position in shares of Iradimed during the fourth quarter worth about $149,000. Snowden Capital Advisors LLC acquired a new position in shares of Iradimed in the 4th quarter worth approximately $229,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Iradimed by 4.7% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 4,577 shares of the medical equipment provider's stock worth $252,000 after purchasing an additional 204 shares during the last quarter. Lazard Asset Management LLC grew its stake in shares of Iradimed by 35.8% in the 4th quarter. Lazard Asset Management LLC now owns 33,292 shares of the medical equipment provider's stock worth $1,831,000 after purchasing an additional 8,773 shares during the last quarter. Finally, Granahan Investment Management LLC grew its stake in shares of Iradimed by 20.2% in the 4th quarter. Granahan Investment Management LLC now owns 12,645 shares of the medical equipment provider's stock worth $695,000 after purchasing an additional 2,124 shares during the last quarter. 92.34% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

IRMD has been the topic of several analyst reports. Roth Mkm reissued a "buy" rating and issued a $72.00 target price (up from $60.00) on shares of Iradimed in a research report on Friday, February 14th. Wall Street Zen upgraded shares of Iradimed from a "buy" rating to a "strong-buy" rating in a report on Tuesday, May 6th.

Iradimed Stock Performance

Shares of IRMD stock traded down $0.42 during trading on Thursday, hitting $60.36. 58,418 shares of the company were exchanged, compared to its average volume of 43,259. The firm has a market capitalization of $767.48 million, a price-to-earnings ratio of 40.24 and a beta of 0.91. The business's 50-day simple moving average is $52.95 and its 200 day simple moving average is $54.59. Iradimed Corporation has a twelve month low of $41.71 and a twelve month high of $63.29.

Iradimed Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, May 30th. Stockholders of record on Tuesday, May 20th were given a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.13%. The ex-dividend date was Tuesday, May 20th. Iradimed's dividend payout ratio is 43.87%.

About Iradimed

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.